Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Sites / University of Maryland School of Medicine / Pickens, Chrisley V.

Pickens, Chrisley V. (B.S.)

Staff, University of Maryland School of Medicine , 410-706-6534

Contact Information

Email: mailto:cpickens@umm.edu
Fax:
Other Lab Staff

To update contact information, please visit the Data Management and Coordinating Center.

Open Protocols

Protocol Name Biomarkers Datasets
Molecular Basis of Barrett's -Associated Carcinogenesis 0 0
Aurora Kinase A as a Biomarker for the Detection of Bladder Cancer - Supplemental Pre-Validation Protocol 0 0
Validation of Biomarkers for the Early Detection of Colorectal Adenocarcinoma (GLNE 010) 0 0
Validation of Molecular Biomarkers for the Early Detection of Lung Cancer in the setting of Indeterminate Pulmonary Nodules (Lung Team Project #2) 0 0

Closed Protocols

Protocol Name Biomarkers Datasets
Detection of Bladder CA by Microsatellite Analysis (MSA) 1 0

Publications

Publication Name PubMed ID Journal
Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. 19072545 J. Proteome Res.
MicroRNAs as potential biomarkers in human solid tumors. 23196059 Cancer Lett.
Magnetic enrichment of bronchial epithelial cells from sputum for lung cancer diagnosis. 18484646 Cancer
Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules. 25593345 Clin. Cancer Res.
A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer. 28376184 J. Natl. Cancer Inst.
Genome-wide small nucleolar RNA expression analysis of lung cancer by next-generation deep sequencing. 25159866 Int. J. Cancer
Amplified RPS6KB1 and CDC2 genes are potential biomarkers for aggressive HIV+/EBV+ diffuse large B-cell lymphomas. 23330000 Int J Clin Exp Pathol
Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer. 23474761 Oncogene
Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target. 17699796 Cancer Res.
Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer. 17255269 Clin. Cancer Res.
An unsupervised approach to identify molecular phenotypic components influencing breast cancer features. 14996713 Cancer Res.
Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach. 16369491 Oncogene
Detecting genomic aberrations by fluorescence in situ hybridization with quantum dots-labeled probes. 18283800 J Nanosci Nanotechnol
Targeted disruption of Aurora A causes abnormal mitotic spindle assembly, chromosome misalignment and embryonic lethality. 18345035 Oncogene
Analysis of small nucleolar RNAs in sputum for lung cancer diagnosis. 26246471 Oncotarget
C-MYC rearrangements are frequent in aggressive mature B-Cell lymphoma with atypical morphology. 18784824 Int J Clin Exp Pathol
Analysis of Lung Flute-collected Sputum for Lung Cancer Diagnosis. 26309391 Biomark Insights
Phospho-p70S6K/p85S6K and cdc2/cdk1 are novel targets for diffuse large B-cell lymphoma combination therapy. 19223503 Clin. Cancer Res.
Differential miRNA expressions in peripheral blood mononuclear cells for diagnosis of lung cancer. 26146958 Lab. Invest.
Evaluation of lung flute in sputum samples for molecular analysis of lung cancer. 24053570 Clin Transl Med
Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer. 20142235 Cancer Epidemiol. Biomarkers Prev.
Analysis of MicroRNAs in sputum to improve computed tomography for lung cancer diagnosis. 24305007 J Thorac Oncol
A panel of sputum-based genomic marker for early detection of lung cancer. 20864512 Cancer Prev Res (Phila)
ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome. 20010854 Lab. Invest.
Relation between normal rectal methylation, smoking status, and the presence or absence of colorectal adenomas. 20572039 Cancer
Characterization of microRNA transcriptome in lung cancer by next-generation deep sequencing. 24785186 Mol Oncol
Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. 19276181 Mol. Cancer Res.

To update protocols, publications, biomarkers, or science data, please contact the Informatics Center.

Addresses

22 South Greene Street, PG201, IMGL Laboratory
University of Maryland School of Medicine

To update addresses, please visit the Data Management and Coordinating Center.

Announcement 03/14/2018
Thank you to everyone to made the 10th EDRN Scientific Workshop a success. The next event is the 33rd EDRN Steering Committee Meeting from September 5-6, 2018 in Boston, MA. Details will be available soon.


Three new FOAs on the Human Tumor Atlas and associated with the Cancer Moonshot Initiative have been released. Please click here for more information.

Announcement 10/23/2017

Three new FOAs on the Human Tumor Atlas and associated with the Cancer Moonshot Initiative have been released. Please click here for more information.

EDRN Founder Honored

Dr. Sudhir Srivastava was honored with the Distinguished Service Award from the American Pancreatic Association at the group's annual meeting this year, for his outstanding commitment to pancreatology.